Metraipolis › archive › dc_809d0a2c324b
Limited utility of imaging-based (N) markers in predicting cerebral spinal fluid Alzheimer's disease biomarker positivity in lecanemab-eligible mild cognitive… — Europe PMC PMID:41426983
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41426983
- DOI
- 10.3389/fneur.2025.1735548
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T22:24:13.207Z
- SHA-256 of the archived text
f18cb635b3cf5a2f9ae54a74ba557c346c7b251a4b6c627dedc00ad93be49405- Stable URL of this page
https://metraipolis.com/documento/dc_809d0a2c324b
How to cite
Limited utility of imaging-based (N) markers in predicting cerebral spinal fluid Alzheimer's disease biomarker positivity in lecanemab-eligible mild cognitive… — Europe PMC PMID:41426983 — Europe PMC (en), https://europepmc.org/article/MED/41426983 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_809d0a2c324b (Metraipolis archive dc_809d0a2c324b, sha256 f18cb635b3cf5a2f9ae54a74ba557c346c7b251a4b6c627dedc00ad93be49405)
BibTeX
@misc{dc809d0a2c324b,
title = {Limited utility of imaging-based (N) markers in predicting cerebral spinal fluid Alzheimer's disease biomarker positivity in lecanemab-eligible mild cognitive… — Europe PMC PMID:41426983},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41426983},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_809d0a2c324b; sha256 f18cb635b3cf5a2f9ae54a74ba557c346c7b251a4b6c627dedc00ad93be49405},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41426983. Agents can read the archived copy with the MCP tool read_document.